Authors contributions
SL summarized the data, reviewed the literature, wrote this manuscript
and included the remarks and corrections of the other authors.
EM contributed to the interpretation of the data, reviewed the
literature and revised the manuscript.
HVN contributed to the
interpretation of the data and revised the manuscript.
LODS contributed to the acquisition of data and their interpretation.
LML contributed to the acquisition of data and their interpretation.
PK contributed to the acquisition of data and their interpretation and
revised the manuscript.
AG contributed to the acquisition of data and their interpretation.
PC contributed to the interpretation of the data, reviewed the
literature and revised the manuscript.
References
- Zhao Q, Meng M, Kumar R,et al. Lymphopenia is associated with severe
coronavirus disease 2019 (COVID-19) infections: A systemic review and
meta-analysis. Int J Infect Dis. 2020 May 4;96:131-135. doi:
10.1016/j.ijid.2020.04.086. Online ahead of print.
- He R, Lu Z, Zhang L, Fan T, et al. The clinical course and its
correlated immune status in COVID-19 pneumonia. J Clin Virol. 2020 Apr
12;127:104361. doi: 10.1016/j.jcv.2020.104361. Online ahead of print.
- Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients
with COVID-19 infection. Am J Hematol 2020; 95: E131-E153 DOI:
10.1002/ajh.25774
- Yao Z, Zheng Z, Wu K,et al. Immune environment modulation in pneumonia
patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
Aging (Albany NY). 2020; 12:7639-7651.
https://doi.org/10.18632/aging.103101
- Liu J, Li S, Liu J, Liang B, et
al. Longitudinal characteristics of lymphocyte responses and cytokine
profiles in the peripheral blood of SARS-CoV-2 infected patients.
Version 2. E Bio Medicine 2020; 55: 102763. doi:
10.1016/j.ebiom.2020.102763
- Rutsaert L, Steinfort N, Van
Hunsel T, et al. COVID‑19‑associated invasive pulmonary aspergillosis.
Ann Intensive Care. 2020 Jun 1;10(1):71
https://doi.org/10.1186/s13613-020-00686-4
- Alanio A, Dellière S, Fodil S, et al. High Prevalence of Putative
Invasive Pulmonary Aspergillosis in Critically Ill COVID-19 Patients
(April 14, 2020), forthcoming. doi.org/10.2139/ssrn.3575581
- Koehler P, Cornely OA, Böttiger BW, et al. COVID-19 Associated
Pulmonary Aspergillosis. Mycosis 2020 Jun;63(6):528-534
doi.org/10.1111/MYC.13096
- van Arkel ALE, Rijpstra TA, Belderbos HNA, et al. COVID-19 Associated
Pulmonary Aspergillosis. Am J Respir Crit Care Med. 2020 Jul
1;202(1):132-135 doi: 10.1164/rccm.202004-1038LE
- Koulenti D, Garnacho-Montero J, Blot S. Approach to invasive pulmonary
aspergillosis in critically ill patients. Curr Opin Infect Dis 2014;
27: 174-83
- D’Ardes D, Boccatona A, Schiavone C, et al. A Case of Coinfection with
SARS-CoV-2 and Cytomegalovirus in the Era of COVID-19. EJCRIM 2020;7:
doi:10.12890/2020_001652
- Lansbury L, Lim B, Baskaran V, et al. Co-infections in people with
COVID-19: a systematic review and meta-analysis, Journal of Infection
2020 May 27;S0163-4453(20)30323-6.
https://doi.org/10.1016/j.jinf.2020.05.046
- Bernard S, Germi R, Lupo J, et al. Symptomatic cytomegalovirus
gastrointestinal infection with positive quantitative real-time PCR
findings in apparently immunocompetent patients: a case series. Clin
Microbiol Infect. 2015;21(12):1121.e1.
- Li X, Huang Y, Xu Z, et al. Cytomegalovirus infection and outcome in
immunocompetent patients in the intensive care unit: a systematic
review and meta-analysis. BMC Infect Dis. 2018 Jun 28;18(1):289. doi:
10.1186/s12879-018-3195-5.
- Heininger A, Jahn G, Engel C, et al. Human cytomegalovirus infections
in nonimmunosuppressed critically ill patients. Crit Care Med.
2001;29(3):541–547. doi: 10.1097/00003246-200103000-00012.
- Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly Targeted Human
Cytomegalovirus-Specific CD4+ and CD8+ T Cells Dominate the Memory
Compartments of Exposed Subjects. J Exp Med 2005;202(5):673-85. doi:
10.1084/jem.20050882.
- Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al. Complex Immune
Dysregulation in COVID-19 Patients with Severe Respiratory Failure.
Cell Host & Microbe 2020; 27: 1-9 doi: 10.1016/j.chom.2020.04.009
- Roncati L, Nasillo V, Lusenti B, et al. Signals of Th2 immune response
from COVID-19 patients requiring intensive care. Ann Hematol 2020
Jun;99(6):1419-1420 doi: 10.1007/s00277-020-04066-7
- Moss P. “The ancient and the new”: is there an interaction between
cytomegalovirus and SARS-CoV-2 infection? Immun Ageing. 2020; 17: 14.
doi: 10.1186/s12979-020-00185-x